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Genes causing nonsyndromic autosomal recessive deafness (DFNB12) and deafness associated with retinitis pig-
mentosa and vestibular dysfunction (USH1D) were previously mapped to overlapping regions of chromosome
10q21-q22. Seven highly consanguineous families segregating nonsyndromic autosomal recessive deafness were
analyzed to refine the DFNB12 locus. In a single family, a critical region was defined between D10S1694 and
D10S1737, ∼0.55 cM apart. Eighteen candidate genes in the region were sequenced. Mutations in a novel cadherin-
like gene, CDH23, were found both in families with DFNB12 and in families with USH1D. Six missense mutations
were found in five families with DFNB12, and two nonsense and two frameshift mutations were found in four
families with USH1D. A northern blot analysis of CDH23 showed a 9.5-kb transcript expressed primarily in the
retina. CDH23 is also expressed in the cochlea, as is demonstrated by polymerase chain reaction amplification from
cochlear cDNA.
Introduction
Usher syndrome (USH) is an autosomal recessive dis-
order characterized by sensorineural hearing loss and
retinitis pigmentosa. There are three clinical subtypes
that can be differentiated on the basis of the severity of
auditory and vestibular dysfunction and the age at onset
of retinitis pigmentosa: USH1, characterized by congen-
ital profound hearing loss, vestibular areflexia, and pre-
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pubertal onset of retinitis pigmentosa; USH2, associated
with moderate-to-severe hearing loss, normal vestibular
function, and onset of retinitis pigmentosa during the
2d decade of life; and USH3, characterized by progres-
sive hearing loss, variable vestibular function, and adult-
onset retinitis pigmentosa (Smith et al. 1994). At least
six loci for USH1 (A–F) have been mapped (Kaplan et
al. 1992; Kimberling et al. 1992; Smith et al. 1992;
Wayne et al. 1996, 1997; Chaib et al. 1997), and two
of the USH1 genes have been identified. Mutations in
MYO7A cause USH1B (MIM 276903 [Weil et al.
1995]), and mutations in USH1C have recently been
shown to underlie USH1C (MIM 605242 [Bitner-Glind-
zicz et al. 2000; Verpy et al. 2000]).
Nonsyndromic deafness is also genetically heteroge-
neous. At present, 38 autosomal dominant and 30 re-
cessive nonsyndromic-deafness loci have been mapped,
and 10 genes underlying autosomal dominant hearing
loss and 7 genes underlying autosomal recessive hearing
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loss have been identified (Morell 1999; Willems 2000;
E. R. Wilcox, Q. L. Burton, S. Naz, S. Riazuddin, T.
N. Smith, I. Belyantseva, T. Ben-Yosef, N. A. Liburd,
R. J. Morell, B. Kachar, D. K. Wu, A. J. Griffith, S.
Riazuddin, and T. B. Friedman, unpublished data). One
of the unidentified loci for autosomal recessive nonsyn-
dromic deafness,DFNB12, had been mapped to 10q21-
q22 (MIM 601386 [Chaib et al. 1996]), where its crit-
ical region was overlapped by the 15-cM interval that
subsequently defined the USH1D region (MIM 601067
[Wayne et al. 1996]).
We have refined the genetic interval of the DFNB12
locus and have screened 18 candidate genes in the linked
region for mutations, in families with DFNB12 and
USH1D.We demonstrate that DFNB12 and USH1D are
allelic disorders caused by mutations in a novel cad-
herin-like gene, CDH23.
Subjects and Methods
Family Enrollment and Diagnosis
Numerous consanguineous families segregating auto-
somal recessive, profound, congenital deafness were as-
certained, including nine Pakistani families (304,
PKSR13a, PKSR3, PKSR46a, PKSR5b, PKSR7a, PKZA3,
PKZA46, and PKZA56), two Indian families (INJ5 and
5020A-AN), and two families of Pakistani and Turkish
descent, respectively, that were living in England (USH05
and USH08). These 13 families demonstrated linkage to
10q21-q22. In addition to audiometry, participating fam-
ily members underwent medical history interviews, phys-
ical examination (including fundoscopy), and, in a subset
of patients, electroretinography. Family 304, the original
family with USH1D, cosegregated symptoms and signs of
retinitis pigmentosa with hearing loss (Wayne et al. 1996).
Appropriate institutional-review board approval and in-
formed consent were obtained for this study.
Linkage Analysis
Genomic DNA was extracted from blood samples by
either a phenol-extraction protocol (Grimberg et al.
1989) or a Puregene DNA-isolation kit (Gentra Sys-
tems); in some cases, buccal epithelial DNA was pre-
pared (Epicenter Technologies). Samples were genotyped
for markers flanking known DFNB loci, by use of
marker information provided by the Hereditary Hearing
Loss Homepage. Short tandem-repeat polymorphisms
(STRPs) were amplified with fluorescent primer pairs
synthesized on an Applied Biosystems 394 DNA/RNA
synthesizer (PE Biosystems) and were analyzed using
standard procedures (Lalwani et al. 1999). For family
5020A-AN, pools of genomic DNA from affected and
from nonaffected persons were screenedwith 169 STRPs
evenly spaced across the human autosomal genome
(Screening set 8A; Research Genetics).
LOD scores were calculated by either the FASTLINK
version of the LINKAGE program package (Lathrop
and Lalouel 1984; Schaffer 1996; Lab of Statistical
Genetics, Rockefeller University) or MAPMAKER/
HOMOZ (Kruglyak et al. 1995; Whitehead Insitute for
Biomedical Research, Center for Genome Research
FTP). The disease-allele frequency was set at .00075, on
the basis of estimates in the Indian population (Zbar et
al. 1998), and the disease was coded as fully penetrant
and autosomal recessive. An allele frequency of .1 for
each allele and a 1/1,000 phenocopy rate were assumed.
Linkage to markers at 10q21-q22 was observed in each
of these families. Linkage analysis for family 304 has
been reported elsewhere (Wayne et al. 1996).
Candidate Gene Screening
Candidate genes in the DFNB12 interval were
screened by direct sequencing of PCR products gener-
ated from genomic DNA of one affected individual from
each family. Primers were designed to amplify all exons
of each candidate gene, including the intron-exon
boundaries. Primer pairs used to sequence exons of
CDH23 from genomic DNA are listed in the Appendix.
Genomic DNAwas amplified by PCR in a 20-ml reaction
volume. Reactions contained 20–50 ng of genomic
DNA, 5 pmol each of forward and reverse primer, 200
mM each dNTP, 1# PCR buffer (PE Biosystems),
1.5–2.5 mM MgCl2 (PE Biosystems), and 0.5 U of ther-
mostable polymerase. The thermal cycling conditions
were as follows: 95C for 2 min; 35 cycles of 95C for
45 s, 60C for 45 s, and 72C for 45 s; and a final
extension at 72C for 15 min. Five microliters of the
PCR reaction products were analyzed by 2.0% agarose
gel electrophoresis. The remaining 15 ml were treated
with 0.3 U of shrimp alkaline phosphatase (Amersham)
and 3 U of exonuclease I (USB) at 37C for 1 h, followed
by 80C for 15 min, then were diluted with 1 vol of
dH2O. Six microliters were then used in 10-ml sequencing
reactions containing 3.2 pmol of primer, 2 ml of Big Dye
Terminator Ready Reaction mix (PE Biosystems), and 1
ml of a dilution buffer (400 mM Tris-HCl pH 9.0 and
10 mMMgCl2). Cycling conditions were 96C for 2 min
and 45 cycles of 96C for 10 s, 55C for 10 s, and 60C
for 4 min. DNA-sequencing reactions were ethanol pre-
cipitated with NaOAc and Pellet Paint NF Co-Precipi-
tant (Novagen) and were resuspended in 2–5 ml of for-
mamide loading dye. Products were separated on 4.25%
DNA-sequencing PAGE gels, were visualized, and were
analyzed using a PE Biosystems ABI Prism 377 DNA
Sequencer and ABI Prism software. The resulting chro-
matograms were analyzed using the PHRED/PHRAP/
28 Am. J. Hum. Genet. 68:26–37, 2001
Table 1
Family Data, Mutations of CDH23 (cadherin-23), and Allele Frequencies
FAMILY PHENOTYPE(S)a
LOD
SCOREb MUTATION(S)
PROTEIN
DOMAIN
ALLELE FREQUENCY IN
Control Population HD Panelc
PKZA56 A, B, C 1.62 Q492X EC5 0/96d 0/182
304e A, B, C 13.0f IVS231GrA EC12 0/96d 0/64
PKSR46a A 3.96 D1243N 0/158d 0/160
USH05 A, B, C 4.11f R1305X EC13 0/78d 0/62
PKSR5b A 2.56 D1400N EC14 0/78d 0/62
PKZA3 A 2.31 D188N EC2 0/126d 0/64
INJ5 A 3.28 I2148N, R2154C MPED 0/96,g 0/48d 0/96
5020A-AN A 2.53f P2257T Prox to TM 0/96g 0/64
PKSR7a A, D 4.80 IVS441GrA Cytoplasmic 0/96d 0/64
PKSR13a A, B, C 4.4
PKSR3 A 3.29
PKZA46 A 1.71
USH08 A, B, C 1.32f
a A p sensorineural hearing loss; B p retinal degeneration; Cp vestibular dysfunction; and Dp atypical late
onset of retinal degeneration and borderline vestibular dysfunction in the two oldest affected individuals.
b Maximum two-point LOD score at recombination fraction 0 for theDFNB12 region, calculated usingMLINK.
c Source: Human Diversity Panel, Coriell Cell Repositories, Camden, NJ.
d Chromosomes typed from normal individuals from Pakistan.
e Original family with USH1D (Wayne et al. 1996).
f Multipoint LOD score over linked region for family, calculated using MAPMAKER/HOMOZ (Whitehead
Institute for Biomedical Research, Center for Genome Research FTP).
g Chromosomes typed from normal individuals from India.
CONSED software suite (Ewing et al. 1998; Gordon et
al. 1998).
Mutations were confirmed by sequence analysis of
DNA from all affected individuals of a given family.
Random normal control DNA samples from either Pak-
istan or India were also analyzed, depending on the eth-
nic origin of the family (table 1), as were panethnic con-
trol samples from The Human Diversity Panel (Coriell
Cell Repositories).
Gene-Prediction Programs
Unfinished genomic sequence from bacterial artificial
chromosomes (BACs) spanning theDFNB12 region was
obtained from GenBank. Known genes were detected by
BLASTN comparison of the BAC sequence against the
nucleotide databases, and novel genes were detected by
sequence similarity to proteins in the public database,
by BLASTX, and/or were predicted by GeneMachine
(GENSCAN and FGENES) software.
cDNA Analysis
PCR primers were designed to hybridize to selected
exons predicted by GENSCAN analysis of genomic se-
quence of BAC 472K8. Overlapping PCR fragments
were generated from aliquots of RACE-ready retinal
cDNA (Clontech) or from human cochlear cDNA pre-
pared using mRNA kindly provided by Dr. C. C.Morton
(Harvard University). PCR reactions were performed in
40 ml as described above, except that 2.5 U of Takara
LA-Taq polymerase (PanVera) were used. Cycling con-
ditions were 95C for 1 min and 45 cycles of 96C for
10 s and 68C for 8 min. Overlapping PCR products
were gel purified and were cloned into PCR-XL-TOPO
vector (Invitrogen). Primers used to generate clones
were clone p132A (5′-CCACAAGGCTTCCCTGTCTA-
3′ and 5′-CACCGTGAATTACCTGGACTACGAG-3′),
clone p132B (5′-CATGGACTTCCTCATCAACAGCA-
G-3′ and 5′-CAGAGTGATGTAGACGCTGCAGAAG-
3′), and clone p116A (5′-TTGGTTGAGGTTGTCGAT-
GG-3′ and 5′-ACGTGGGTGGAGGTACTGCT-3′). In
addition, the predicted CDH23 sequence was used as a
BLAST query against a database of expressed-sequence
tags generated from cDNA libraries of various ocular
tissues (G. Wistow and S. L. Bernstein, unpublished
data). Two clones from a human retinal pigmented ep-
ithelium library were identified, one of which (cs53A06)
was used in the determination of the cDNA sequence.
cDNA fragments were sequenced as described above
(622 bp for clone p116A, 2,083 bp for clone cs53A06,
1,104 bp for clone p132B, and 6,177 bp for clone
p132A) and were assembled using Seqman software
(DNAStar).
Northern Blot Analysis
Human donor eyes (ages 54 and 60 years) and human
occipital cortex (age 74 years) were obtained from the
National Disease Research Interchange. Total RNA was
isolated from dissected ocular tissues and brain, by use
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of RNAzolB (Tel-Test). Ten micrograms each of total
RNA from retina, ciliary body, retinal pigmented epi-
thelium-choroid, lens, iris, and human brain, along with
a 9.5–0.24-kb RNA standard ladder (Life Technologies),
were electrophoresed on an agarose-formaldehyde de-
naturing gel and were transferred to GeneScreen Plus
membrane (Dupont-NEN). RNA loading per lane was
monitored using the 18S rRNA band (Correa-Rotter et
al. 1992). This northern blot and a commercially ob-
tained multiple-tissue northern blot (MTNHuman Blot;
Clontech) were hybridized with a random primed, triple-
labeled ([a32P]-dATP, -dCTP, and -dGTP) 488-bp cDNA
probe generated from the cytoplasmic domain of
CDH23, by use of primers rm102 (5′-GCGGAGCAT-
GAGGATGACCT-3′) and rm103 (5′-AGGCCCTTCT-
GGTCTTCCTC-3′) to amplify cochlear cDNA. Nor-
thern blots were hybridized at 63C in Hybrisol II
(Intergen) for 18 h and were washed at 63C in 0.2#
SSC and 0.1% SDS.
Results
Clinical Data
Nonsyndromic autosomal recessive sensorineural
hearing loss was diagnosed in affected individuals in
families 5020A-AN (age 12 years), INJ5 (age 55
years), PKSR46a (age 25 years), PKSR5b (age 20
years), PKZA3 (age 16 years), and PKZA46 (age 9
years). Both the absence of retinitis pigmentosa or other
cosegregating extra-auditory features and normal de-
velopmental motor milestones were confirmed by the
medical histories and physical examinations. Ocular fun-
doscopy was performed on selected (usually the two old-
est) affected individuals of each family, to determine the
absence of retinitis pigmentosa.
Family PKSR3 segregates profound sensorineural
deafness and demonstrates evidence for linkage to the
DFNB12 region (table 1). No obvious fundoscopic ab-
normalities were observed in affected family members;
however, they were not examined by an ophthalmolo-
gist. The two oldest affected individuals (ages 35 and
29 years) had delayed onset of independent ambulation
(age 1.5–2 years), and only the oldest had decreased
night vision and abnormal vestibular function. In light
of the available clinical data, it is not clear whether the
deafness segregating in this family is nonsyndromic or
syndromic.
Affected individuals of families 304 (Wayne et al.
1996), USH05, USH08, PKSR13a, and PKZA56 have
typical USH1 phenotypes, according to the criteria rec-
ommended by the Usher Syndrome Consortium (Smith
et al. 1994). All affected individuals have profound deaf-
ness, evidence of vestibular dysfunction, and retinitis
pigmentosa that, in almost all affected individuals, began
during the 1st decade of life. For example, the affected
individuals in family PKZA56 are ages 5 and 11 years,
and both manifest signs of peripheral vestibulopathy,
including delayed onset of independent ambulation (age
2 years) and persistent imbalance in walking and bicycle
riding. Both children have congenital profound senso-
rineural hearing loss and pigmentary retinopathy. A di-
agnosis of retinitis pigmentosa was established by fun-
doscopic examination of both children and was con-
firmed by electroretinographic evaluation in the 11-year-
old child.
In contrast, family PKSR7a segregates an atypical
USH1 phenotype. All five affected individuals have con-
genital profound sensorineural hearing loss. Although
the two oldest affected individuals exhibit borderline ab-
normal vestibular function in the tandem-gait and Rom-
berg tests, they had normal developmental motor mile-
stones, similar to their siblings. With the exception of
the oldest affected individual (age 28 years), who has
slightly decreased night vision, the affected individuals
of PKSR7a denied decreased night or peripheral vision.
The two oldest affected subjects (ages 27 and 28 years)
demonstrated mild pigmentary retinopathy by fundos-
copic examination, consistent with early pathological
changes of retinitis pigmentosa (fig. 1). The younger sib-
lings had no obvious fundoscopic evidence of retinitis
pigmentosa, although they were not examined by an
ophthalmologist and did not undergo electroretinogra-
phy. Pedigrees for the consanguineous families segre-
gating mutant alleles of CDH23 are shown in figure 1,
except for family 304, which has been described else-
where (Wayne et al. 1996).
Genetic and Physical Map
Genotype analysis of markers in the DFNB12 region
was performed on all participating members of each
family. Genotype and haplotype data for PKSR46a de-
fine the smallest critical interval, shown in figure 1. In-
dividual 27 of PKSR46a has normal hearing levels, as
shown by pure-tone audiometry, and is homozygous for
markers in the proximal portion of the linked haplotype,
with a recombination, at D10S1694, defining the prox-
imal breakpoint of the linked region. Individual 29 of
PKSR46a is profoundly deaf and has a crossover, at
D10S1737, defining the distal breakpoint of the linked
region.
The genetic and physical maps of the linked region
are depicted in figure 2. Also shown is a BAC contig
that almost completely spans this region. These BACs
are being sequenced by the Sanger Centre and Human
Genome Therapeutics, as part of the Human Genome
Project. Known or predicted genes that were sequenced
in the families with DFNB12/USH1D are listed in the
right margin of figure 2. Numerous homozygous se-
Figure 1 Pedigrees of five consanguineous families with DFNB12 and of three families with USH1D, segregating mutant alleles ofCDH23.
The pedigree for family 304, who are affected by USH1D, has been published elsewhere (Wayne et al. 1996). Blackened symbols represent
individuals with clinically documented congenital deafness, retinal degeneration, and vestibular dysfunction, as described in the key. Genotype
and haplotype data for family PKSR46a are shown. For theDFNB12 locus, the haplotype of unaffected individual 27 demonstrates the proximal
breakpoint, at D10S1694, and that of affected individual 29 demonstrates the distal breakpoint, at D10S1737. 152N13aat is a polymorphic
trinucleotide repeat identified on BAC 152N13.
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Figure 2 Genetic and physical map of the DFNB12 locus de-
fined by proximal and distal breakpoints in family PKSR46a. The
Center forMedical Genetics,MarshfieldMedical Research Foundation
map distance of polymorphic markers is shown on the left. The prox-
imal breakpoint, markerD10S1694, and the distal breakpoint,marker
D10S1737, are shown as crosses on the chromosome, and the linked
markers are shown as blackened circles on the chromosome. Both the
BACs spanning the linked region and the 18 candidate genes that were
sequenced for mutations are shown. Locus designations are italicized.
Nonitalicized entries represent either clones that have no associated
locus designation or novel genes that have significant homology to
other genes. There are two gaps in the BAC contig, and 150D20 is
the only BAC in the region with a finished sequence.
quence changes were found in these candidate genes dur-
ing our mutation screen, but, in 16 of the 18 genes se-
quenced, all changes showed high allele-carrier rates
among normal controls and were considered to be poly-
morphisms (data not shown). One exception was a ho-
mozygous CrG change in exon 7 of HSGT1 in family
PKSR7a, which is predicted to result in the substitution
of a glycine for arginine at amino acid position 281.
This change was not found either in 70 chromosomes
from ethnically matched controls or in 92 chromosomes
from panethnic controls. However, no other nonpoly-
morphic changes in HSGT1 were found in our other
families with DFNB12 and USH1D, and the significance
of this amino acid substitution, if any, is not known. All
other nonpolymorphic changes were found in the novel
gene CDH23.
Identification of USH1D and DFNB12
CDH23 was detected initially as three separate GEN-
SCAN-predicted genes distributed among several se-
quence contigs from BACs 570J13 and 472K8, spanning
120 kb. Several exons of one of the predicted genes
are identical to a partial cDNA sequence of clone
DKFZp434P2350 recovered from testis (GenBank ac-
cession number AL122081). The conceptual translations
of all three predicted genes showed homology to cad-
herin-like genes, which encode integral membrane pro-
teins involved in cell adhesion. Cadherins typically have
large extracellular domains (characterized by cadherin
repeats), a membrane-spanning region, and cytoplasmic
domains that are highly divergent among family mem-
bers (Nollet et al. 2000).
Two of the three cadherin-like predicted genes in the
DFNB12-linked region encode only extracellular do-
mains with cadherin repeats, whereas the third predicted
gene encodes cadherin repeats and a predicted trans-
membrane-spanning domain, followed by ∼300 amino
acids. It was possible to orient the sequence contigs rel-
ative to one another and to design primers to the pre-
dicted exons to amplify overlapping cDNAproducts that
spanned the three predicted genes. By use of retinal and
cochlear cDNAs as PCR templates, as well as a cDNA
clone from a human retinal pigmented epithelium library
identified by sequence similarity, it was possible to de-
duce 7.5 kb of continuous sequence of a single transcript
with an open reading frame encoding 2,552 amino acids
(fig. 3).
The predicted protein shows 28% identity and 43%
similarity to theDrosophila fat gene (GenBank accession
number M80537) and 27% identity and 41% similarity
to the human FAT gene (GenBank accession number
X87241). This novel gene has been assigned the locus
designation “CDH23,” for cadherin-related 23, by the
HUGO nomenclature committee. The extracellular do-
main contains 20 cadherin repeat (EC) domains, as pre-
dicted by BLAST-CD, with expect scores ranging from
to 0.45. There is also a single transmembrane do-81
main and a 268-amino-acid cytoplasmic domain that
shows no similarity to either any other proteins or any
protein domains in the pfam- or smart-motif databases.
Northern blots of human RNA probed with 488 bp
of sequence from the unique cytoplasmic domain dem-
onstrate a 9.5-kb mRNA, possibly a doublet, expressed
specifically in the retina, indicating that another ∼2.0 kb
of cDNA sequence remains to be identified (fig. 4). The
5′ end of our transcript does not contain a methionine
start codon in Kozak (1987) consensus context. There-
fore, it is likely that the 5′ end of the CDH23 transcript
is incomplete. A polyadenylation site for CDH23 is pre-
dicted, by GENSCAN, to be 651 bp downstream of the
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Figure 3 CDH23 cDNAs and the structure of the cadherin-23 protein (GenBank accession number AY010111). Mutations described in
the text are indicated below the protein structure, and the 1GrA donor–splice-site mutations are indicated above the structure, by arrows.
Intron 15 of CDH23 contains a nested gene (FLJ00041 [GenBank accession number AK024449]) encoded on the opposite strand. BLAST
analysis reveals that the probable mouse orthologues of CDH23 and FLJ00041 are encoded on BAC RP23-161B11. EC denotes the extracellular
cadherin repeat, and TM denotes a transmembrane spanning region, as predicted by TMpred.
Figure 4 Northern blot analysis. Lanes 1–6 contain 10 mg each
of total RNA from retina, ciliary body, retinal pigmented epithelium-
choroid, lens, iris, and brain. Positions of bands from a 9.5–0.24-kb
RNA ladder are indicated along the right margin. Shown is a 4-d
exposure to autoradiograph film. The 9.5-kb band for human retina
is possibly a doublet. A 1-wk exposure to a PhosphoImager screen
shows identical results, with the presence of no additional bands (data
not shown).
TGA stop codon (fig. 3), and only 1.6 kb of genomic
sequence separates the TGA stop codon ofCDH23 from
the 3′ UTR of the PSAP (prosaposin) gene.
Hybridization to macula and peripheral retinal total
RNA from monkey indicated that the 9.5-kb message is
expressed in both retinal regions (data not shown). No
signal was seen for human RNA from heart, brain, pla-
centa, lung, liver, skeletal muscle, or kidney when a mul-
tiple-tissue northern blot was hybridized with the same
probe, whereas a single 1.35-kb band was observed in
pancreas (data not shown).
The existence of alternative splice forms of CDH23
is suggested by the northern blot analyses. During the
generation of the northern blot probe, PCR primerswere
designed to amplify a 488-bp fragment from cochlear
cDNA. Sequence analyses of several cloned fragments
identified a 383-bp fragment in which exon 46 was omit-
ted. The reading frame is preserved in these clones, with
the resulting predicted peptide lacking 35 amino acids
from the cytoplasmic domain. Moreover, the partial
cDNA sequence of clone DKFZp434P2350 shows exact
sequence similarity to 703 bp of CDH23, but the last
463 bp of DKFZp434P2350 apparently represents either
alternate exons not recovered in our experiments or in-
tronic sequence from a partially spliced message. Given
the possibility of alternative splicing, we screened for
mutations of CDH23 in an additional 14 exons pre-
dicted from genomic DNA, as well as in 42 of the 47
exons represented in our cDNAs. We found two non-
sense and two splice-site mutations among four families
with USH1D and six missense mutations among five
families with DFNB12 (table 1). All of the mutations
were in the 47 exons represented in the cDNA depicted
in figure 3.
The six amino acid substitutions were found in all
families with DFNB12: PKSR46a, PKSR5b, 5020A-AN,
PKZA3, and INJ5 (table 1 and figs. 3 and 5). Of the six
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Figure 5 Nucleotide sequence of mutations in representative
families with USH1D and DFNB12, with wild-type sequence shown
below the mutant allele. The nucleotide and protein sequences of
CDH23 and cadherin-23 are based on data for GenBank accession
number AY010111. Arrows indicate the altered nucleotide of the mu-
tant CDH23 allele. A, Mutation of conserved donor splice site in
family 304, with USH1D (Wayne et al. 1996). The canonical GTdonor
dinucleotides are underlined, and the splice site is indicated by an
arrowhead. B, Nonsense mutation in family PKZA56, with USH1D
leading to premature termination of translation. C,Missense mutation
in family PKSR46a, with DFNB12, with aspartic acid replaced by an
asparagine.
substitutions, five (D1243N, D1400N, D188N, I2148N,
and R2154C) occur in EC domains. Two mutations co-
segregate in the INJ5 family—I2148N and R2154C.
Both substitutions occur at the distal end of the
membrane proximal extracellular cadherin domain
(MPED). It is not clear whether one or a combination
of these substitutions causes the mutant phenotype,
although neither was observed in 240 control
chromosomes.
The mutations segregating in the four families with
USH1D (PKZA56, 304, UHS05, and PKSR7a) were ei-
ther nonsense (Q492X and R1305X) or splice-site mu-
tations (IVS231GrA and IVS441GrA) (table 1 and
fig. 5). The nonsense mutations in families PKZA56 and
USH05 both occur in EC domains. Splice-site mutations
in families 304 and PKSR7a alter the invariant G of
the donor–splice-site GT dinucleotide to an A. The
IVS231GrA mutation segregating in family 304 is in
the EC12 domain (figs. 3 and 5). The functional con-
sequence of this mutation is difficult to predict. GEN-
SCAN analysis predicts an alternate donor site 43 nu-
cleotides downstream. Use of this alternate donor site
would maintain the reading frame and would predict
the use of an additional exon in intron 23 and the re-
sumption of the EC domains downstream of exon 24.
The mutation in the1 donor site of intron 44 in family
PKSR7a, which has USH1D, is in the region encoding
the cytoplasmic domain. GENSCAN predicts an alter-
nate donor site 37 nucleotides downstream and the use
of an alternate acceptor site for exon 45, which is 20
nucleotides upstream. Use of these alternate splice sites
is predicted to add a total of 19 in-frame amino acids
and to preserve the open reading frame of the protein.
We did not identify mutant alleles in four of the fam-
ilies having homozygosity by descent in the DFNB12
region. Two of these families are too small to support
significant evidence of linkage, and it is possible that
they exhibit spurious homozygosity in the DFNB12 re-
gion. However, two of these families, PKSR13a and
PKSR3, support evidence for linkage to CDH23 (table
1). Mutations causing USH1D and DFNB12 in these
families may be found in the ∼2.0 kb of CDH23 cDNA
that we have not yet recovered from our libraries.
Discussion
Cadherins comprise a large family of intercellular ad-
hesion proteins. The classical cadherins encode repeated
extracellular motifs that have been demonstrated to pro-
vide cell-to-cell adhesion via homophilic, calcium-de-
pendent interactions, whereas cytoplasmic domains in-
teract with the cytoskeleton via b-catenin (Nollet et al.
2000). An extensive family of atypical cadherins, or cad-
herin-like proteins, shares homology in the EC domains
and presumably mediates similar functions involving
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cell-cell or cell–extracellular membrane interactions.
One of these atypical cadherins, fat, has been charac-
terized in Drosophila, where it was demonstrated that
fat mutations resulted in imaginal disc overgrowth (Ma-
honey et al. 1991).
The novel cadherin-like gene described here has sim-
ilarity to fat and to a human homologue, FAT. The
similarity to fat proteins is entirely in the EC domains.
CDH23 differs from fat and FAT in not having a lam-
inin A-G domain—nor does it have any similarity in its
cytoplasmic domain. Thus, CDH23 may represent a
new class of cadherin-like proteins.
CDH23 is also remarkable in its limited tissue dis-
tribution. FAT transcripts are detected on northern blots
of numerous epithelial tissues, including kidney, lung,
breast, colon, arterial smoothmuscle, and retina (Dunne
et al. 1995). Northern blot analysis of CDH23 suggests
that it is limited to the neuroretina. The pancreas may
express a highly homologous or short alternate (∼1.4
kb) transcript (data not shown). We also have dem-
onstrated cochlear expression of CDH23, by sequenc-
ing of PCR products from a human cochlear cDNA
library.
Cochlear and retinal expression of CDH23 is con-
sistent with the observed phenotypes of nonsyndromic
deafness (DFNB12) and USH1D. CDH23 is the second
known example of a gene associated with both non-
syndromic deafness and USH. Mutations in the uncon-
ventional myosinMYO7A can causeDFNA11,DFNB2,
or USH1B (Weil et al. 1995, 1997; Liu et al. 1997a,
1997b), although there is no clear correlation between
the type ofMYO7Amutation and the phenotype (Keats
and Corey 1999). In contrast, the six missense CDH23
mutations segregate in families with DFNB12, whereas
the two nonsense mutations segregate in families with
USH1D. The CDH23 splice mutations were associated
with typical USH1D in one family and with a mild,
atypical USH1D in a second family. In this latter family,
affected persons had no obvious vestibular dysfunction,
and the retinal degeneration observed in the two oldest
individuals (ages 27 and 28 years) was mild and had
late onset. It is possible that the young affected indi-
viduals of the families with DFNB12 may develop ret-
initis pigmentosa at an atypically late age; however, their
normal developmental motor milestones and lack of
vestibular abnormalities are most consistent, at this
time, with DFNB12 deafness.
CDH23 is the second gene encoding a protein in-
volved in adhesion in which mutations cause USH. The
USH2A gene encodes a protein with homology to lam-
inin, a constituent of the extracellular matrix (ECM;
Eudy et al. 1998 [MIM 276901]). The presence of re-
peated laminin-like and fibronectin-like motifs in
USH2A has led to the speculation that this protein is
either a tissue-specific component of the ECM or an
adhesion molecule that regulates cellular interactions
with the ECM (Eudy et al. 1998). The genotype-phe-
notype correlation of USH2A parallels that of CDH23,
in that frameshift mutations of USH2A cause deafness
and retinitis pigmentosa, whereas homozygosity for a
missense mutation (C759F) causes retinitis pigmentosa
alone (Rivolta et al. 2000). Compound heterozygosity
for a frameshift mutation and C759F leads to an in-
termediate phenotype, with retinitis pigmentosa and
mild hearing loss (Rivolta et al. 2000).
The role of cadherin-23 in the cochlea and retina, the
molecular partners interacting with the cytoplasmic do-
main, and the effects of the mutations described here
may be addressed by direct experimentation with ex-
pression constructs and animal models. An animal
model for CDH23 mutations may already exist, since
the region surrounding CDH23 shows conserved syn-
teny with mouse chromosome 10, where several mu-
tations causing deafness have been mapped, including
waltzer, jackson circler, ames waltzer, and age-related
hearing loss (Ahl) (Bryda et al. 1997; Johnson et al.
1997; Alagramam et al. 2000). Possible homology to
the Ahl gene is particularly intriguing, since age-related
hearing loss occurs in almost 50% of the population by
age 80 years (Morton 1991). Nonsyndromic autosomal
recessive deafness occurs in 1/1,000 live births, with an
unknown percentage attributable to mutations at the
DFNB12 locus. Recently, it has been proposed that
USH1D is the second most common type of USH1 (As-
tuto et al. 2000). Thus, the elucidation of the role of
cadherin-23 in cochlear and retinal development and
function may significantly influence the diagnosis and
treatment of deafness and deafness-blindness world-
wide.
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Appendix
Table A1
Genomic Primer Sequences from the Introns Adjacent to 42 Exons of
CDH23
Exon Forward Reverse
Product Length
(bp)
1a ctcagtgaaggggtctgctc gtaccccagaggcccagt 299
2 ctcaccacttgccttcttcc cctatccttttcctgccaca 396
3 gaagcatccatcccagtgtc cacactgagcacacagcaga 316
4 tgactcccttgggaattcat cagaggctaaagcccaacag 406
5 ccactcctggactcaccatc aggcaccctgtgtgaactct 283
6 gaagtgtgcccctctctcag ctctggtgccactgagcat 297
7 ctgggtggcattcaagaagt cctcatctcccagacctttg 195
8 aggaggggactggtgaactt tgttctagctgtgggcttgg 313
9 ggaaagcagtgaccacacaa tggggaggtttgctctga 239
10 tctatctgggactgcacagc tgcacacagaaggagctcaa 499
11 acgtgacaggccttgtccta aggacatgggattggaagtg 579
12 agggtttgctgatgttccag ggatcctggctgtttcactc 304
14 ttagccctgactccagttgc cccccgtatgtccagctat 205
15 tacaggagcaggtgccagac ttgggcagatggactaaagg 454
16 tcgcagacataggagtggtg ataggtttcgccccttgtct 506
17 cagtggttccccatcacag aggacaggggtcttggattt 365
18 tggctaagcttttccaccat ggtgttctcgccacatctct 405
19 ggcttgctagaggaagcaga cccaaagagttgctggatgt 400
20 ttctccatgaccaactgcac tagggcagggtcctcttttt 398
21 aatttagggaggccaagcag aatggaggccaagaggagtt 401
22 ccaacctaccaaccctcctc acccactggggtctaggttc 301
23 ctcccctctcatccatcgt gctgtgaaaaatggggtctc 361
24 gcaccccttttctgtgtgtt aactccgtgtccaacctgag 338
25 ctcccttttccctctccaac gagaaagaagggggaagcag 561
26 cagccacaagtcccagattc ttggctctgagtgaccaatg 297
27 ggtcacctagcccttcctct cttggggactaagcaagcag 502
28 aatgaggagtggccaaaatg gggcagggagagagagtagg 413
29 gggactgaccttggcctact acttttggtggctgctcagt 259
30 tggccatagtaggtgctcaa ccacttgctagaggctttgc 268
31 ctccttacctttggccttga cacgcttccctctactcctg 301
32 tactctcctgctcccactgc ccactcttctaggccacagc 303
34 actgtgctcttccgctccta tgtttccgtgtctagccaaa 251
35 ctgaaacagggactggaagc gggcatatgtgggtcatctc 260
36 ccatgatcccaccctcag ggaagaggcaggtggtgtaa 343
37 ttacaccacctgcctcttcc ccagatgacagtccatgcag 256
38 tgagtctctgagccgtaccc ccttccttctccctccactg 346
39 gggtctatttgcagggaagg cagacaggctgacagtccaa 242
40 gctgaggaggagagctgaga aggaggatagccaggacgat 263
44 tcacaccccaagtcagtgaa ccccttaaagaacccagctt 350
45 gcctctgctccagctaacat aacctcagccaagggactg 202
46 tgtaccccttactcccagagg ccggctactcagagatggag 199
47 ccacatagccagtgggtctc ccacaaggcttccctgtcta 435
a As shown in fig. 3, we have not characterized ∼2 kb of cDNA 5′ to exon
1 that probably encodes several additional EC domains.
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